A detailed history of Pathstone Holdings, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 2,251 shares of BIO stock, worth $788,367. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,251
Previous 2,370 5.02%
Holding current value
$788,367
Previous $647,000 16.38%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$263.97 - $344.64 $31,412 - $41,012
-119 Reduced 5.02%
2,251 $753,000
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $442,360 - $559,802
-1,649 Reduced 41.03%
2,370 $647,000
Q1 2024

May 13, 2024

BUY
$304.11 - $351.99 $395,343 - $457,587
1,300 Added 47.81%
4,019 $1.39 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $732,417 - $992,543
2,719 New
2,719 $877,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.63B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.